Charles River Laboratories International Inc $ 138.64 0.68 (0.49%)
| Volume: | 600,802 | Avg Vol (1m): | 324,932 |
| Market Cap $: | 6.77 Bil | Enterprise Value $: | 8.77 Bil |
| P/E (TTM): | 31.37 | P/B: | 4.60 |
Manual of Stocks™ Web
Financial Strength | 4.4/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 0.09 | ||
| Equity-to-Asset | 0.32 | ||
| Debt-to-Equity | 1.51 | ||
| Debt-to-EBITDA | 4.25 | ||
| Interest Coverage | 5.19 | ||
| Piotroski F-Score | 5 | ||
| Altman Z-Score | 2.19 | ||
| Beneish M-Score | -2.53 | ||
| WACC vs ROIC | |||
Profitability |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 13.74 | ||
| Net Margin % | 8.94 | ||
| ROE % | 16.57 | ||
| ROA % | 5.45 | ||
| ROC (Joel Greenblatt) % | 31.43 | ||
| 3-Year Revenue Growth Rate | 17.3 | ||
| 3-Year EBITDA Growth Rate | 17.3 | ||
| 3-Year EPS without NRI Growth Rate | 13.4 |
Ratios |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 31.37 | ||
| Forward PE Ratio | 18.87 | ||
| PE Ratio without NRI | 31.37 | ||
| Price-to-Owner-Earnings | 25.11 | ||
| PB Ratio | 4.6 | ||
| PS Ratio | 2.79 | ||
| Price-to-Free-Cash-Flow | 25.41 | ||
| Price-to-Operating-Cash-Flow | 16.99 | ||
| EV-to-EBIT | 25.92 | ||
| EV-to-EBITDA | 16.93 | ||
| EV-to-Revenue | 3.58 | ||
| PEG Ratio | 2.08 | ||
| Shiller PE Ratio | 66.85 | ||
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.38 | ||
| Days Inventory | 30.12 | ||
| Days Sales Outstanding | 62.43 | ||
| Days Payable | 23.31 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.9 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Intrinsic-Value-Projected-FCF | 1.46 | ||
| Price-to-Median-PS-Value | 1.25 | ||
| Price-to-Peter-Lynch-Fair-Value | 2.03 | ||
| Earnings Yield (Greenblatt) % | 3.86 | ||
| Forward Rate of Return (Yacktman) % | 19.18 |